The Global Trial Site Database Brings into J&J, Merck, Lilly

The R&D is stepping closer to globalization, for example, recently J&J, Merck and Eli Lilly, the three pharma giants, is reportedly begun to create a "one-stop" database to help streamline their work with clinical trial sites worldwide.

The objective of their action is to collect and share information in one research site, as well as display on hand equipment or good clinical practice training. The clinical trial innovation head of J&J told the Reuters, "The clinical practice won't get any better if the investigators take it repeatedly."

This effect enlists direct input from an international network of more than 100,000 investigators. Their move is just a representative of the future trends.